In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding
All posts tagged in UK life sciences
4Articles
The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,
Britain is poised to miss out on billions in pharmaceutical R&D investment and access to new medicines unless urgent reforms are made to the NHS medicine rebate system, according to
Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
